Stay Current on H. pylori Treatment Guidance

February 2025

You’ll see a shift in the treatment of H. pylori infections...based on recent guidelines from Am Coll of Gastroenterology (ACG).

Regimens that include the antibiotic rifabutin...or the newer gastric-acid suppressing med, vonoprazan (Voquezna)...now have a role as first-line options in some cases.

And resistance to common antibiotics, clarithromycin and levofloxacin, continues to rise.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

  • 12 issues every year — what you need to know and do, right now
  • Quick, practical reference charts and tools
  • Comprehensive CE library to meet license renewal and state requirements
  • Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
  • Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote